Streetbeat News

Stock Prices

WINT

Windtree Therapeutics reported that serious adverse events related to worsening heart failure occurred less frequently in patients treated with Istaroxime compared to those given a placebo. The rates were 5.3% for the Istaroxime group versus 18.2% for the placebo group.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:21 pm

WINT

Windtree Therapeutics announced positive Phase 2b clinical results for istaroxime, showing significant improvements in cardiac function and blood pressure in heart failure patients with early cardiogenic shock. The study met its primary endpoint, with istaroxime outperforming placebo in improving systolic blood pressure.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:17 pm

EMKR

Emcore shares rise as Mobix Labs offers to acquire the company for $3.80 per share in an all-cash deal.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:16 pm

KZR

Trading for a certain asset has been halted at 8:15:00 a.m. ET due to pending news. This could indicate significant upcoming information that may impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:15 pm

RLYB

Rallybio Corporation presented nonclinical data on ENPP1 inhibition as a therapeutic approach for hypophosphatasia at the ASBMR 2024 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:13 pm

CCG

Cheche Group's CEO and Chairman, Lei Zhang, has purchased Class A shares in the open market, indicating confidence in the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:09 pm

BYRN

EVEX

LICN

NVVE

RAYA

SMXT

SRFM

TTEC

XPON

In Monday's pre-market session, TTEC Holdings, Eve Holding, and SolarMax Technology saw significant stock price increases, while Expion360, Erayak Power Solution, Byrna Technologies, Lichen China, Surf Air Mobility, and Nuvve Holding experienced declines.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

EJH

KAVL

KXIN

MRM

NIO

ZCMD

In Monday's pre-market session, several consumer discretionary stocks experienced significant movements. Kaixin Holdings (KXIN) and ZHONGCHAO (ZCMD) saw substantial gains, while MEDIROM Healthcare Techs (MRM) and Kaival Brands Innovations (KAVL) experienced declines.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

ADXN

ANAB

BNOX

BWAY

CRVS

ENSC

ESLA

PRME

PTIX

THAR

TRAW

VERO

In Monday's pre-market session, several healthcare stocks experienced significant movements. Prime Medicine, Traws Pharma, and Tharimmune saw notable gains, while Ensysce Biosciences and Corvus Pharma faced declines. Earnings reports influenced some stock movements.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

BTDR

EMKR

NA

OCFT

In Monday's pre-market session, several information technology stocks experienced significant movements. EMCORE (EMKR) saw a remarkable 132.2% increase, while OneConnect Financial Tech (OCFT) rose by 16.75%. On the downside, Nano Labs (NA) decreased by 12.0%, and Bitdeer Technologies (BTDR) fell by 9.6%.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm